Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 6 (June)

1. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
   J Proteome Res, 6(6): 2304-14. [Abstract] [Full-text]
2. Short telomere length and breast cancer risk: a study in sister sets.
   Cancer Res, 67(11): 5538-44. [Abstract] [Full-text]
3. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents.
   Cancer Res, 67(11): 5513-21. [Abstract] [Full-text]
4. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
   Cancer Res, 67(11): 5505-12. [Abstract] [Full-text]
5. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
   Cancer Res, 67(11): 5337-44. [Abstract] [Full-text]
6. Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification.
   Cancer Res, 67(11): 5308-17. [Abstract] [Full-text]
7. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation.
   Cancer Res, 67(11): 5293-9. [Abstract] [Full-text]
8. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
   Cancer Res, 67(11): 5134-40. [Abstract] [Full-text]
9. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.
   Cancer Res, 67(11): 5083-9. [Abstract] [Full-text]
10. Breast cancer surgery in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study.
    J Am Coll Surg, 204(6): 1235-41. [Abstract] [Full-text]
11. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Histopathology, 50(7): 875-80. [Abstract] [Full-text]
12. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Histopathology, 50(7): 866-74. [Abstract] [Full-text]
13. Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia.
    Histopathology, 50(7): 859-65. [Abstract] [Full-text]
14. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells.
    Biochim Biophys Acta, 1773(6): 903-11. [Abstract] [Full-text]
15. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Clin Biochem, 40(9): 623-8. [Abstract] [Full-text]
16. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems.
    Pharm Res, 24(7): 1262-74. [Abstract] [Full-text]
17. Different criteria for radioactive sentinel lymph nodes has different impact on sentinel node biopsy in breast cancer patients.
    J Surg Oncol, 95(8): 635-9. [Abstract] [Full-text]
18. Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.
    Biochem Biophys Res Commun, 358(4): 1076-9. [Abstract] [Full-text]
19. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy.
    Int J Radiat Oncol Biol Phys, 68(3): 935-42. [Abstract] [Full-text]
20. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Int J Radiat Oncol Biol Phys, 68(3): 662-6. [Abstract] [Full-text]
21. A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.
    Int J Radiat Oncol Biol Phys, 68(3): 839-44. [Abstract] [Full-text]
22. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
    Int J Radiat Oncol Biol Phys, 68(3): 667-72. [Abstract] [Full-text]
23. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients.
    Int J Radiat Oncol Biol Phys, 68(3): 673-81. [Abstract] [Full-text]
24. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines.
    J Cell Physiol, 212(2): 293-7. [Abstract] [Full-text]
25. Regional lymph node irradiation in breast cancer.
    Future Oncol, 3(3): 343-52. [Abstract] [Full-text]
26. Three-dimensional nanometry of vesicle transport in living cells using dual-focus imaging optics.
    Biochem Biophys Res Commun, 359(1): 1-7. [Abstract] [Full-text]
27. TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions.
    Exp Mol Pathol, 83(1): 54-8. [Abstract] [Full-text]
28. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.
    Am J Clin Oncol, 30(3): 310-4. [Abstract] [Full-text]
29. Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane.
    Am J Clin Oncol, 30(3): 297-302. [Abstract] [Full-text]
30. An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma.
    Am J Clin Oncol, 30(3): 294-6. [Abstract] [Full-text]
31. C-reactive protein and risk of breast cancer.
    J Natl Cancer Inst, 99(11): 890-4. [Abstract] [Full-text]
32. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    J Natl Cancer Inst, 99(11): 881-9. [Abstract] [Full-text]
33. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.
    BMC Cancer, 7: 83. [Abstract] [Full-text]
34. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience.
    Br J Radiol, 80(952): 267-73. [Abstract] [Full-text]
35. Risk factors for induction of breast cancer by X-rays and their implications for breast screening.
    Br J Radiol, 80(952): 261-6. [Abstract] [Full-text]
36. Metastatic carcinoma of the breast: the appearances of metastatic spread to the abdomen and pelvis as demonstrated by CT.
    Br J Radiol, 80(952): 284-92. [Abstract] [Full-text]
37. Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women.
    Cancer Causes Control, 18(6): 595-602. [Abstract] [Full-text]
38. NSAIDs and breast cancer recurrence in a prospective cohort study.
    Cancer Causes Control, 18(6): 613-20. [Abstract] [Full-text]
39. The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.
    Cancer Causes Control, 18(6): 621-5. [Abstract] [Full-text]
40. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
    J Clin Endocrinol Metab, 92(6): 2197-200. [Abstract] [Full-text]
41. Social disparities in breast and cervical cancer preventive practices.
    Eur J Cancer Prev, 16(4): 372-9. [Abstract] [Full-text]
42. Induction of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by Bcl-2 family regulation and MEK/ERK signaling.
    Eur J Cancer Prev, 16(4): 342-7. [Abstract] [Full-text]
43. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation.
    Eur J Cancer Prev, 16(4): 334-41. [Abstract] [Full-text]
44. High-intensity focused ultrasound ablation of breast cancer.
    Expert Rev Anticancer Ther, 7(6): 823-31. [Abstract] [Full-text]
45. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
    Toxicol Appl Pharmacol, 221(3): 372-83. [Abstract] [Full-text]
46. Surgical management of breast cancer.
    Semin Oncol, 34(3): 234-40. [Abstract] [Full-text]
47. Bilaterally symmetric juvenile fibroadenomas and tubular breast deformity in a prepubescent girl.
    J Pediatr Surg, 42(6): 1133-6. [Abstract] [Full-text]
48. Management strategies for pain in breast carcinoma patients: current opinions and future perspectives.
    Pain Pract, 7(2): 163-77. [Abstract] [Full-text]
49. Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells.
    J Toxicol Environ Health A, 70(13): 1108-15. [Abstract] [Full-text]
50. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors.
    J Clin Oncol, 25(17): 2352-9. [Abstract] [Full-text]
51. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity.
    J Clin Oncol, 25(17): 2345-51. [Abstract] [Full-text]
52. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
    J Clin Pathol, 60(6): 649-55. [Abstract] [Full-text]
53. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    J Clin Oncol, 25(17): 2360-8. [Abstract] [Full-text]
54. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
    J Control Release, 120(1): 18-26. [Abstract] [Full-text]
55. Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?
    Cancer, 109(12): 2627-34. [Abstract] [Full-text]
56. Environmental pollutants and breast cancer: epidemiologic studies.
    Cancer, 109(12): 2667-711. [Abstract] [Full-text]
57. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention.
    Cancer, 109(12): 2635-66. [Abstract] [Full-text]
58. Reported drop in mammography : is this cause for concern?
    Cancer, 109(12): 2405-9. [Abstract] [Full-text]
59. Diet and breast cancer: a review of the prospective observational studies.
    Cancer, 109(12): 2712-49. [Abstract] [Full-text]
60. HER2 testing in the UK: consensus from a national consultation.
    J Clin Pathol, 60(6): 685-9. [Abstract] [Full-text]
61. Examination of breast needle core biopsy specimens performed for screen-detected microcalcification.
    J Clin Pathol, 60(6): 681-4. [Abstract] [Full-text]
62. Expression of nuclear insulin receptor substrate 1 in breast cancer.
    J Clin Pathol, 60(6): 633-41. [Abstract] [Full-text]
63. Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?
    J Clin Pathol, 60(6): 690-3. [Abstract] [Full-text]
64. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
    J Pathol, 212(3): 335-44. [Abstract] [Full-text]
65. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
    Cancer Lett, 253(1): 89-96. [Abstract] [Full-text]
66. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
    Cancer Lett, 253(1): 34-42. [Abstract] [Full-text]
67. Correlates of women's cancer screening and contraceptive knowledge among female emergency department patients.
    BMC Womens Health, 7: 7. [Abstract] [Full-text]
68. Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells.
    Bioorg Med Chem, 15(15): 5122-36. [Abstract] [Full-text]
69. RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis traces.
    BMC Mol Biol, 8: 38. [Abstract] [Full-text]
70. Estimating the benefits of mammography screening: the impact of study design.
    Epidemiology, 18(4): 487-92. [Abstract] [Full-text]
71. Smoking cigarettes before first childbirth and risk of breast cancer.
    Am J Epidemiol, 166(1): 55-61. [Abstract] [Full-text]
72. Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study.
    Am J Epidemiol, 166(1): 46-54. [Abstract] [Full-text]
73. Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study.
    Cancer Chemother Pharmacol, 60(3): 365-73. [Abstract] [Full-text]
74. Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
    Invest New Drugs, 25(4): 369-75. [Abstract] [Full-text]
75. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
    Cytopathology, 18(3): 191-6. [Abstract] [Full-text]
76. Treating one of our own.
    Clin J Oncol Nurs, 11(2): 227-31. [Abstract] [Full-text]
77. Management of benign tumors of the adolescent breast.
    Plast Reconstr Surg, 120(1): 13e-19e. [Abstract] [Full-text]
78. Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases.
    J Am Acad Dermatol, 57(1): 126-33. [Abstract] [Full-text]
79. The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
    Cancer, 111(3): 173-84. [Abstract] [Full-text]
80. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Cancer, 111(3): 185-91. [Abstract] [Full-text]
81. Benign glandular inclusions a rare cause of a false positive sentinel node.
    J Surg Oncol, 95(7): 593-6. [Abstract] [Full-text]
82. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
    J Surg Oncol, 95(7): 567-71. [Abstract] [Full-text]
83. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    J Surg Res, 141(1): 53-9. [Abstract] [Full-text]
84. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
    Biochem Biophys Res Commun, 359(3): 716-22. [Abstract] [Full-text]
85. Bone mineral density in breast cancer patients with positive estrogen receptor tumor status.
    Maturitas, 57(3): 221-5. [Abstract] [Full-text]
86. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
    J Clin Oncol, 25(18): 2522-7. [Abstract] [Full-text]
87. Lost opportunities: physicians' reasons and disparities in breast cancer treatment.
    J Clin Oncol, 25(18): 2516-21. [Abstract] [Full-text]
88. Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
    J Clin Oncol, 25(18): 2509-15. [Abstract] [Full-text]
89. Markers of the uPA system and common prognostic factors in breast cancer.
    Am J Clin Pathol, 128(1): 112-7. [Abstract] [Full-text]
90. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
    Am J Clin Pathol, 128(1): 86-91. [Abstract] [Full-text]
91. p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.
    Am J Clin Pathol, 128(1): 80-5. [Abstract] [Full-text]
92. Limited family structure and BRCA gene mutation status in single cases of breast cancer.
    JAMA, 297(23): 2587-95. [Abstract] [Full-text]
93. CT-guided core needle biopsy of breast lesions visible only on MRI.
    AJR Am J Roentgenol, 189(1): 152-4. [Abstract] [Full-text]
94. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence.
    AJR Am J Roentgenol, 189(1): 140-4. [Abstract] [Full-text]
95. "I'm pregnant and I have breast cancer".
    BMC Cancer, 7: 93. [Abstract] [Full-text]
96. Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.
    BMC Cancer, 7: 92. [Abstract] [Full-text]
97. Dairy products, calcium and the risk of breast cancer: results of the French SU.VI.MAX prospective study.
    Ann Nutr Metab, 51(2): 139-45. [Abstract] [Full-text]
98. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study.
    Cancer Causes Control, 18(7): 775-82. [Abstract] [Full-text]
99. Pleomorphic adenoma of the breast should be excised with a cuff of normal tissue.
    Breast J, 13(4): 418-20. [Abstract] [Full-text]
100. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
     Breast J, 13(4): 413-7. [Abstract] [Full-text]
101. Synchronous male breast cancer and carcinoma of prostate in 90-year-old male, presented with spinal cord compression and multiple spine lytic lesions.
     Breast J, 13(4): 410-2. [Abstract] [Full-text]
102. Communication with older breast cancer patients.
     Breast J, 13(4): 406-9. [Abstract] [Full-text]
103. Radioguided localization of clinically occult breast lesions (ROLL): a pilot study.
     Breast J, 13(4): 401-5. [Abstract] [Full-text]
104. Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience.
     Breast J, 13(4): 392-400. [Abstract] [Full-text]
105. Breast cancer in Iran: an epidemiological review.
     Breast J, 13(4): 383-91. [Abstract] [Full-text]
106. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer.
     Breast J, 13(4): 374-82. [Abstract] [Full-text]
107. Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.
     Breast J, 13(4): 368-73. [Abstract] [Full-text]
108. The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
     Breast J, 13(4): 359-67. [Abstract] [Full-text]
109. Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients - a retrospective study.
     Breast J, 13(4): 352-8. [Abstract] [Full-text]
110. Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.
     Breast J, 13(4): 337-45. [Abstract] [Full-text]
111. Diagnostic accuracy of the Gail model in the Black Women's Health Study.
     Breast J, 13(4): 332-6. [Abstract] [Full-text]
112. Lymph node status and breast cancer-related lymphedema.
     Ann Surg, 246(1): 42-5. [Abstract] [Full-text]
113. Aromatase inhibitors in post-menopausal metastatic breast carcinoma.
     Expert Opin Investig Drugs, 16(7): 1023-36. [Abstract] [Full-text]
114. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
     Nat Clin Pract Oncol, 4(7): 415-23. [Abstract] [Full-text]
115. Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.
     J Clin Pathol, 60(7): 808-15. [Abstract] [Full-text]
116. Genome-wide association study identifies novel breast cancer susceptibility loci.
     Nature, 447(7148): 1087-93. [Abstract] [Full-text]
117. External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme.
     J Clin Pathol, 60(7): 816-9. [Abstract] [Full-text]
118. Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
     Cancer Immunol Immunother, 56(9): 1485-99. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.